Showing 6,981 - 7,000 results of 12,750 for search '"therapeutics"', query time: 0.09s Refine Results
  1. 6981

    Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis by Yujie Xiao, Yixuan Yuan, Dahai Hu, Hongtao Wang

    Published 2024-01-01
    “…Furthermore, this review evaluates exosome-based therapeutic miRNA delivery systems in sepsis, which may pave the way for targeted modulation of the septic response and personalized treatment options.…”
    Get full text
    Article
  2. 6982

    Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review by C.N. Williams

    Published 1987-01-01
    “…There are no controlled dose-response studies of 5-ASA in patients with Crohn's disease. Thus, the most "therapeutic" dose is not known. The author's anecdotal evidence reports char patients with Crohn's disease affecting the rectum or left colon respond poorly to 5-ASA enemas. …”
    Get full text
    Article
  3. 6983

    The Protective Potential Role of ACE2 against COVID-19 by Fereshteh Golab, Gelareh Vahabzadeh, Leila SadeghRoudbari, Arefeh Shirazi, Robabeh Shabani, Sara Tanbakooei, Lida Kooshesh

    Published 2023-01-01
    “…Due to the coronavirus disease 2019 (COVID-19), researchers all over the world have tried to find an appropriate therapeutic approach for the disease. The angiotensin-converting enzyme 2 (ACE2) has been shown as a necessary receptor to cell fusion, which is involved in infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …”
    Get full text
    Article
  4. 6984

    Torsion-Induced Traumatic Optic Neuropathy (TITON): A physiologically relevant animal model of traumatic optic neuropathy. by Annie K Ryan, Brooke I Asemota, Tyler Heisler-Taylor, Claire Mello, Luis Rodriguez, William E Sponsel, Julie Racine, Tonia S Rex, Randolph D Glickman, Matthew A Reilly

    Published 2025-01-01
    “…TON is characterized by axon damage in the optic nerve followed by retinal ganglion cell death in the days and weeks following injury. At present, no therapeutic or surgical approach has been found to offer any benefit beyond observation alone. …”
    Get full text
    Article
  5. 6985

    FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways. by Qing Li, Yan Li, Tong Zhou, Yong Zhang, Huiyu Li, Fajia Yuan, Yanghui Bi

    Published 2025-01-01
    “…The research findings provide a theoretical foundation for the prognostic prediction and therapeutic planning of CRC based on metabolic reprogramming.…”
    Get full text
    Article
  6. 6986

    Mistakes in the diagnosis and treatment of atopic dermatitis by Monika Marko, Rafał Pawliczak

    Published 2024-02-01
    “…We emphasized that current diagnostic and therapeutic guidelines are recommended. Therefore, based on European Guideline EuroGuiDerm, we indicate what is inappropriate in treating AD and highlight the most important aspects of this disease management that practitioners should remember. …”
    Get full text
    Article
  7. 6987

    Integrating psychological and mental health perspectives in disease management: improving patient well-being by Francesca Grosso

    Published 2025-02-01
    “…Communication gaps between health professionals and patients, influenced by beliefs and expectations, risk giving rise to two errors that can compromise the therapeutic alliance: the concept of self-fulfilling prophecy and the nocebo effect. …”
    Get full text
    Article
  8. 6988

    Monte Carlo Simulations in Nanomedicine: Advancing Cancer Imaging and Therapy by James C. L. Chow

    Published 2025-01-01
    “…This review explores the critical role of MC simulations in modeling complex biological interactions, optimizing NP designs, and enhancing the precision of therapeutic and diagnostic strategies. Key findings highlight the ability of MC simulations to predict NP bio-distribution, radiation dosimetry, and treatment efficacy, providing a robust framework for addressing the stochastic nature of biological systems. …”
    Get full text
    Article
  9. 6989

    Radical-Scavenging Effect, Ferric Reducing Ability and Phytochemical Analysis of Urtica urens (L.) and Mercurialis annua (L.) by Doukkali Zouhra, Meryem El Jemli, Abdelhakim Bouyahya, Khang Wen Goh, Ganesh Sritheran Paneerselvam, Belatar Bahia, Yahia Cherrah, Katim Alaoui

    Published 2023-06-01
    “…In addition, all active extracts were subjected to phytochemical screening to determine the key groups of chemicals implicated in their therapeutic activity. Total phenolic and flavonoid concentrations were also measured to see how they affected the antioxidant properties of the plant extracts. …”
    Get full text
    Article
  10. 6990

    Role of Macrophages in the Pathogenesis of Atopic Dermatitis by Sadaf Kasraie, Thomas Werfel

    Published 2013-01-01
    “…Further studies should be performed to clarify the dysregulated mechanism of macrophages activation in AD, and this would allow us to target these cells with versatile functions for therapeutic purpose and improve and control the disease. …”
    Get full text
    Article
  11. 6991

    Calcium Mass Balances in Bicarbonate Hemodialysis by Carlo Basile

    Published 2011-01-01
    “…Dialysate calcium (Ca) concentration should be viewed as part of the integrated therapeutic regimen to control renal osteodystrophy and maintain normal mineral metabolism. …”
    Get full text
    Article
  12. 6992

    Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature within the Process of Vascular Remodeling: Cellular Basis, Clinical Relevance, and Implications for Stem Cell Th... by Diana Klein

    Published 2016-01-01
    “…Further, a particular advantage for the therapeutic application of VW-MPSCs for improving vascular function or preventing vascular damage will be discussed.…”
    Get full text
    Article
  13. 6993

    Uncommon BRAF Mutations Associated with Durable Response to Immunotherapy in Patients with Metastatic Melanoma by Brenen P. Swofford, Jade Homsi

    Published 2017-01-01
    “…Further research and clinical trials are needed to study patients with uncommon BRAF mutations and the potential therapeutic benefit of immunotherapy.…”
    Get full text
    Article
  14. 6994

    The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics by Preethi Krishnan, Sambasivarao Damaraju

    Published 2018-01-01
    “…They have also demonstrated clinical significance as potential biomarkers and therapeutic targets for several diseases, including cancer. …”
    Get full text
    Article
  15. 6995

    deutetrabenazine for the treatment of chorea associated with Huntington’s disease by Harshit Gupta, Wil Perkins, Cain Stark, Sathya Kikkeri, Juyeon Kakazu, Adam D. Kaye, Alan D. Kaye

    Published 2022-06-01
    “…Deutetrabenazine is thought to function as an inhibitor of the VMAT2 vesicular monoamine transporter resulting in decreased monoamine release, including dopamine, in the synaptic cleft which has a therapeutic effect in management of chorea. This drug was approved by the FDA in 2017 with a specific indication for tardive dyskinesia and choreiform movement in Huntington’s disease. …”
    Get full text
    Article
  16. 6996

    State-of-the-Art Techniques to Causally Link Neural Plasticity to Functional Recovery in Experimental Stroke Research by Anna-Sophia Wahl

    Published 2018-01-01
    “…The tools discussed are useful to close the loop from our understanding of stroke pathology to the behavioral outcome and may allow discovering new targets for therapeutic approaches. The here presented methods open up new possibilities to assess the efficiency of rehabilitative strategies by understanding their external influence for intrinsic repair mechanisms on a neurobiological basis.…”
    Get full text
    Article
  17. 6997

    CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES by Ugo Testa, Patrizia Chiusolo, Elvira Pelosi, Germana Castelli, Giuseppe Leone

    Published 2024-02-01
    “…Thus, six FDA-approved commercial CAR-T cell products that target antigens preferentially expressed on malignant B-cells or plasma cells have been introduced in the therapy of B-cell lymphomas, B-ALLs and multiple myeloma. These therapeutic successes have triggered the application of CAR-T cell therapy to other hematologic tumors, including T-cell malignancies. …”
    Get full text
    Article
  18. 6998

    Video assisted thoracic surgery. Experiences in Dr. Gustavo Aldereguia Lima hospital. by Arístides Sánchez Sánchez, Lidia Torres Aja, Rubén Mena Guerra, Francisco Cabarroca Castillo

    Published 2008-04-01
    “…There was a prevalence of therapeutic surgeries (55 %), over diagnostic surgeries. …”
    Get full text
    Article
  19. 6999

    Structural insights into antibody-based immunotherapy for hepatocellular carcinoma by Masaud Shah, Muhammad Hussain, Hyun Goo Woo

    Published 2025-01-01
    “…While traditional approaches like surgical resection and tyrosine kinase inhibitors struggle against the tumor’s immune evasion, monoclonal antibody (mAb)-based immunotherapies have emerged as promising alternatives. Several therapeutic antibodies that counter the immunosuppressive tumor microenvironment have demonstrated efficacy in clinical trials, leading to FDA approvals for advanced HCC treatment. …”
    Get full text
    Article
  20. 7000

    Advances in retina genetics: Progress, potential, and challenges by Mayank Bansal

    Published 2025-01-01
    “…We highlight key advancements such as the advent of next-generation sequencing, which has exponentially enhanced the discovery of genetic mutations, thus also enabling personalized medicine/therapeutic approaches. Stem cells, gene augmentation, and gene-editing techniques such as CRISPR/Cas9 are discussed, in which we highlight ongoing research as well as their potential in the targeted treatment of retinal diseases. …”
    Get full text
    Article